Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain

William D Schlaff, Sandra Ann Carson, Anthony A. Luciano, Anthony Luciano, Doug Ross, Agneta Bergqvist
Fertility and sterility · 2006 · vol. 85(2) , pp. 314–325 · doi:10.1016/j.fertnstert.2005.07.1315 · PMID:16595206 · W2017780870
article OA: closed CC0 ⤵ 129 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-06 ⓘ

This study compared the efficacy of subcutaneous depot medroxyprogesterone acetate to leuprolide acetate in alleviating endometriosis-associated pain.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Endometriosis Leuprolide Medroxyprogesterone Acetate Pain Pain Palliative Care Adult Bone Density Bone Density Delayed-Action Preparations Endometriosis Endometriosis Estrogens Estrogens Female Flushing Flushing Humans Injections, Subcutaneous Leuprolide

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (30)

Cited by (50)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:15:23.967219+00:00
License: CC0 · commercial use OK